Artemis Medicare (ARTEMISMED)
STALWARTFairStock Score: 27/100 — RISKY
Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹232.75 |
| Market Cap | ₹3,797.77 Cr |
| P/E Ratio | 38.2 |
| ROCE | 14.88% |
| ROE | 12.19% |
| Dividend Yield | 0.19% |
| Profit Growth | 19.59% |
| Debt/Equity | 0.31 |
| Sales Growth | 17.73% |
| Promoter Holding | 58.39% |
| 52-Week Range | ₹203.35 — ₹297.5 |
| Sector | Healthcare Services |
| Book Value | ₹50.47 |
Artemis Medicare trades with a P/E ratio of 38.2, ROCE of 14.88%, ROE of 12.19%, profit growth of 19.59%, debt-to-equity of 0.31. The FairStock Score of 27/100 flags concerns across multiple fundamental dimensions that investors should examine carefully.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer